Venous Thrombosis
📧 Sign up to get email alerts when something new happens for Venous Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-05-04Clinical Trial Update: Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis [Phase 1, Phase 2]
A Phase 1/2 study evaluating the radiopharmaceutical 99mTc-rBitistatin for imaging venous thrombosis was withdrawn.
-
EMA withdrawal · 2014-07-29EMA Withdrawn: Revasc (desirudin) — Canyon Pharmaceuticals Ltd.
MAH Canyon Pharmaceuticals withdrew Revasc (desirudin) from the EMA; therapeutic area venous thrombosis.
-
EMA withdrawal · 2008-05-16EMA Withdrawn: Quixidar (fondaparinux sodium) — Glaxo Group Ltd.
The EMA indicates withdrawal of Quixidar (fondaparinux sodium) from the market by Glaxo Group Ltd., covering indications including venous th…